INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Quotient Technology Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Quotient Technology Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quotient Technology Inc. (“Quotient” or “the Company”) (NYSE: QUOT) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Quotient reported its financial results for the third quarter of 2020 on November 5, 2020. The Company’s revenue fell short of consensus expectations, and it also reported, for the three and nine months ending September 30, 2020, “restructuring charges of zero and $1.5 million, respectively, certain acquisition related costs of $0.4 million and $1.0 million, respectively, and loss contingency of $2.0 million related to a contract dispute resulting from a retailer’s failure to perform certain obligations related to a guaranteed distribution fee arrangement for both respective periods.” Based on this news, shares of Quotient fell by nearly 22% on the next day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

The Schall Law Firm

Brian Schall, Esq.

310-301-3335

[email protected]

www.schallfirm.com

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo

IIROC Trading Halt – XLY

Canada NewsWire

VANCOUVER, BC, Nov. 24, 2020 /CNW/ – The following issues have been halted by IIROC:

Company: Auxly Cannabis Group Inc.

TSX-Venture Symbol: XLY

All Issues: Yes

Reason: At the Request of the Company Pending News

Halt Time (ET): 9:27 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

Program for Oncopeptides virtual Capital Markets Day on November 30 is published

PR Newswire

STOCKHOLM, Nov. 24, 2020 /PRNewswire/ — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announces that the company has finalized the program for the upcoming virtual capital markets day for investors, analysts and journalists on November 30th, 2020. The program is available on the company’s website at: www.oncopeptides.com/en/calendar/

The CMD will be webcasted live and accessible at: https://tv.streamfabriken.com/oncopeptides-cmd-2020.

The presentations from the capital markets day will be uploaded on the company website in conjunction with the meeting.

Oncopeptides Virtual Capital Markets Day

14.00 – 16.00 CET (8:00am-10am EST) November 30th, 2020

“Building a Fully Integrated Biotechnology Company”

Introduction and Strategy for Value Growth – Marty J Duvall, CEO Oncopeptides

Multiple Myeloma

“Myeloma remains one of the largest unmet medical needs within hematology” 

  • Assistant Professor Joshua Richter, MD. Icahn School of Medicine at Mount Sinai Hospital, New York

Relapsed refractory multiple myeloma and melflufen – clinical experience with melflufen

Panel discussion

  • Professor Paul Richardson, MD, Dana-Farber Cancer Institute, Boston
  • Associate Professor Maria-Victoria Mateos, MD, PhD, University Hospital, Salamanca

Moderated by Klaas Bakker, MD, PhD, CMO Oncopeptides

The clinical development program for melflufen

“Understanding how melflufen can help patients the most” –
Jakob Lindberg, CSO Oncopeptides

Successfully making the drug available for patients in the US

Overview of US launch of melflufen – Marty J Duvall, CEO Oncopeptides

Questions and Answers

For more information, please contact:

Rein Piir, Head of Investor Relations, Oncopeptides
E-mail: [email protected] 
Cell phone: +46 70 853 72 92

The information was submitted for publication at 15.30 CET on November 24, 2020.

About Oncopeptides

Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The lead product candidate melflufen, is a first in class peptide-drug conjugate that targets aminopeptidases and rapidly releases alkylating agents into tumor cells. Melflufen is in development as a new treatment for the hematological malignancy multiple myeloma and is being tested in multiple clinical studies including the pivotal phase 2 HORIZON study and the ongoing phase 3 OCEAN study. Based on the results from the HORIZON study a New Drug Application has been submitted to the U.S. Food and Drug Administration, FDA, for accelerated approval of melflufen in combination with dexamethasone for treatment of adult patients with triple-class refractory multiple myeloma. The FDA, has granted the New Drug Application a priority review, with a PDUFA date of February 28, 2021.Oncopeptides’ global Headquarters is in Stockholm, Sweden and the U.S. Headquarters is situated in Boston, Mass. The company is listed in the Mid Cap segment on Nasdaq Stockholm with the ticker ONCO. More information is available on www.oncopeptides.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/oncopeptides-ab/r/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published,c3242741

The following files are available for download:


https://mb.cision.com/Main/15404/3242741/1339295.pdf

Press release – Program for Oncopeptides virtual Capital Markets Day

Cision View original content:http://www.prnewswire.com/news-releases/program-for-oncopeptides-virtual-capital-markets-day-on-november-30-is-published-301179789.html

SOURCE Oncopeptides AB

Western Copper and Gold Closes $28.75 Million Financing

PR Newswire

VANCOUVER, BC, Nov. 24, 2020 /PRNewswire/ – Western Copper and Gold Corporation (“Western” or the “Company) (TSX: WRN) (NYSE American: WRN) is pleased to announce that it has closed the previously announced offering (the “Offering”) of common shares of the Company (the “Common Shares”), with a syndicate of underwriters led by Cormark Securities Inc. as sole bookrunner, and including CIBC World Markets Inc., H.C. Wainwright & Co., LLC and Roth Capital Partners, LLC (collectively the “Underwriters”).

With the Underwriters having exercised in full the over-allotment option, the Company has issued a total of 19,828,300 Common Shares at a price of $1.45 per Common Share for aggregate gross proceeds of approximately $28.75 million.

In connection with the Offering, the Company paid the Underwriters a cash commission equal to 2.5% of $12.0 million in gross proceeds raised pursuant to sales to members of the president’s list and 5.0% of the gross proceeds from the remainder of the Offering, including proceeds received from the exercise of the over-allotment option.

The Company intends to use the net proceeds from the sale of the Common Shares to fund its exploration, engineering and permitting activities and for general working capital purposes.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, nor will there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. The securities being offered have not been approved or disapproved by any regulatory authority, nor has any such authority passed upon by the accuracy or adequacy of the Prospectus Supplements, the Base Shelf Prospectuses or the Registration Statement.

ABOUT WESTERN COPPER AND GOLD CORPORATION

Western Copper and Gold Corporation is developing the Casino Project, Canada’s premier copper-gold mine in the Yukon Territory and one of the most economic greenfield copper-gold mining projects in the world. For more information, visit www.westerncopperandgold.com.

On behalf of the board,

“Paul West-Sells”

Dr. Paul West-Sells
President & CEO
Western Copper and Gold Corporation

Cautionary Disclaimer Regarding Forward-Looking Statements and Information

This news release contains certain forward-looking statements concerning the Offering and the use of proceeds therefrom, anticipated developments in Western’s operations in future periods and other matters that may occur in the future. Statements that are not historical fact are “forward-looking statements” as that term is defined in the United States Private Securities Litigation Reform Act of 1995 and “forward looking information” as that term is defined in National Instrument 51-102 (“NI 51-102”) of the Canadian Securities Administrators (collectively, “forward-looking statements”). Forward-looking statements are frequently, but not always, identified by words such as “expects”, “anticipates”, “believes”, “intends”, “estimates”, “potential”, “possible” and similar expressions, or statements that events, conditions or results “will”, “may”, “could” or “should” occur or be achieved. These forward-looking statements may include, but are not limited to, statements regarding the anticipated use of proceeds and other future plans; or other statements that are not statement of fact. In making the forward-looking statements herein, the Company has applied certain material assumptions including, but not limited to, the assumptions that the Company will be able to raise additional capital as necessary; the circumstances surrounding the COVID-19 pandemic, although evolving, will stabilize or at least not worsen; that the extent to which COVID-19 may impact the Company, including without limitation disruptions to the mobility of Company personnel, increased labour and transportation costs, and other related impacts, will not change in a materially adverse manner; that all regulatory approvals required to complete the Company’s planned exploration and development activities will be received in a timely manner and on acceptable terms; that the Company is able to procure personnel, equipment and supplies required for its exploration and development activities in sufficient quantities and on a timely basis; and that general business conditions will not change in a materially adverse manner.

Forward-looking statements are statements about the future and are inherently uncertain, and actual results, performance or achievements of Western and its subsidiaries may differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements due to a variety of risks, uncertainties and other factors. Such risks and other factors include, among others, risks involved in fluctuations in gold, copper and other commodity prices and currency exchange rates; COVID-19 risks to employee health and safety and a slowdown or temporary suspension of operations in geographic locations impacted by an outbreak; uncertainties related to raising sufficient financing in a timely manner and on acceptable terms; and other risks and uncertainties disclosed in Western’s AIF and Form 40-F, and other information released by Western and filed with the applicable regulatory agencies.

Western’s forward-looking statements are based on the beliefs, expectations and opinions of management on the date the statements are made, and Western does not assume, and expressly disclaims, any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as otherwise required by applicable securities legislation. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/western-copper-and-gold-closes-28-75-million-financing-301179788.html

SOURCE Western Copper and Gold Corporation

Gray Files Supreme Court Brief Supporting Modernized Television Station Ownership Rules

Atlanta, Georgia, Nov. 24, 2020 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray,” “we,” or “our”) (NYSE: GTN) announced today that it has filed in the US Supreme Court an amicus brief supporting the reversal of a lower court decision that hinders efforts by the Federal Communication Commission (“FCC”) to modernize its broadcast ownership rules.  The brief can be viewed at www.gray.tv/2020amicusbrief

Over the last 15 years, the FCC has attempted repeatedly to update its regulations in light of today’s competitive media marketplace, as directed to do so by statute.  The FCC, however, has been stymied consistently by the US Court of Appeals for the Third Circuit, which effectively has frozen the regulatory landscape as it existed in 1941 when the FCC first adopted a “one-to-market” rule and when the media marketplace was enormously different than it is today.

Gray’s brief argues that the FCC’s modernized rules should finally be allowed to take effect because the agency issued them in full compliance with its obligations under Section 202(h) of the Telecommunications Act of 1996. 

The appeal arises from the FCC’s most recent effort to update its broadcast ownership rules under Section 202(h), which provides that the FCC “shall review its rules” every four years, “shall determine whether” they are “necessary in the public interest as the result of competition,” and, if they are not, “shall repeal or modify” them.  Gray’s amicus brief contends that the proper interpretation of Section 202(h) is that it requires the FCC to consider—first and foremost—the effects of marketplace “competition” when modernizing its rules, and the Third Circuit’s ruling is incorrect because it requires the agency to elevate other policy considerations over the effects of “competition.”  At issue in this case are modernized regulations that the FCC issued in 2017 after considering the ever-increasing competition from low-cost digital media sources, which undercuts the development of high-quality local news and journalism.

Gray’s brief also argues that the Third Circuit’s decision harms small and mid-sized communities around the nation by depriving them of the benefits of the FCC’s updated broadcast ownership rules.  These communities require substantial investment in order to receive high-quality local news and community programming.  Gray’s business model and experience in developing and delivering award-winning local news and community programming illustrate firsthand that the FCC’s modernized regulations would facilitate those necessary and important investments.

David Mills, Elizabeth Prelogar, Robert McDowell, and Barrett Anderson of Cooley LLP prepared and filed the amicus brief on Gray’s behalf.  Gray anticipates a ruling by the Supreme Court by June 2021.


About Gray:

Gray currently owns and/or operates television stations and leading digital properties in 94 television markets, including the number-one rated television station in 68 markets and the first or second highest rated television station in 86 markets.  Gray’s television stations cover approximately 24 percent of US television households and broadcast approximately 400 separate programming streams, including nearly 150 affiliates of the CBS/NBC/ABC/FOX networks.  Gray also owns video program production, marketing, and digital businesses including Raycom Sports, Tupelo-Raycom, and RTM Studios, the producer of PowerNation programs and content.  For further information, please visit www.gray.tv.

#          #          #



Gray Contact Information: 

Website:  www.gray.tv

Kevin P. Latek, Executive Vice President, Chief Legal and Development Officer, 404-266-8333

SCYNEXIS to Participate in Piper Sandler and Evercore ISI Conferences

JERSEY CITY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the Company’s participation in Piper Sandler’s 32nd Annual Virtual Healthcare Conference. Presentations will be available for registered attendees via the Piper Sandler conference site from November 23 to December 3, 2020. The Company will also participate in a panel discussion at Evercore ISI’s 3rd Annual HealthCONx Conference taking place on December 2, 2020.

Presentation details
:

Piper Sandler 32

nd

Annual Virtual Healthcare Conference:
Presentation Date: Monday, November 23 to Thursday, December 3, 2020
Presentation Time: 8:00 a.m. – 5:00 p.m. ET
Webcast: Link
 
Evercore ISI 3

rd

Annual HealthCONx Conference
:
Panel Discussion Topic: No Fungus Among Us: Addressing an Important Need with Cidara, F2G, and SCYNEXIS
Presentation Date: Wednesday, December 2, 2020
Presentation Time: 11:20 a.m. – 12:05 p.m. ET
 

A webcast of both presentation recordings will be available for 30 days and can be found on the Scynexis website at: https://www.scynexis.com/news-media/events.

About SCYNEXIS

SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to potentially help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. Our lead candidate, ibrexafungerp (formerly known as SCY-078), is a broad-spectrum, IV/oral antifungal agent representing a novel therapeutic class, in late stage development for multiple indications, ranging from vaginal yeast infections to life-threatening fungal infections in hospitalized patients. The SCYNEXIS team has deep expertise in anti-infective drug development and marketing, which can be leveraged to advance ibrexafungerp from clinical development to commercialization. For more information, visit www.scynexis.com.


CONTACT



Investor Relations

Irina Koffler
LifeSci Advisors
Tel: (646) 970-4681
[email protected]

Media Relations

Gloria Gasaatura
LifeSci Communications
Tel: (646) 970-4688
[email protected]

 



View Systems, Inc.’s (VSYM) Sannabis Announces Issuance of Fabrication, Production, and Export License by Colombia’s Ministry of Health for Cannabis THC and Hemp Derivatives to Supply a Market Growing at 23% annually.

Company already selling hemp seed oil products approved by INVIMA, Colombia’s FDA.

Cali, Colombia, Nov. 24, 2020 (GLOBE NEWSWIRE) — View Systems, Inc.’s
(

VSYM

), medical marijuana and hemp subsidiary, Sannabis S.A.S. (“the Company”) announces they received notice yesterday from Colombia’s Health Ministry of Resolution 1606 of 2020 issuing Sannabis S.A.S. a Cannabis Derivative Fabrication License. This is one of four Cannabis Licenses needed in Colombia, and the only one issued by the Ministry of Health. This license allows for export of THC and Hemp/CBD cannabis derivatives around the World. Click here to see a copy of the notice.

Sannabis will make further announcements on the issuance of the 3 Ministry of Justice Licenses.

  1. Seed Use License- Seed Bank registers and Certifies Seeds. Coveted since no more license applications accepted.
  2. Non-psychoactive (Hemp) License- allows cultivation of < 1% THC Cannabis (Hemp).
  3. Psychoactive (THC) License- allows cultivation of > 1% THC.

Although the Seed Use (Seed Bank) License is issued by the Ministry of Justice, it needs to be approved by the Colombia Agriculture Institute (ICA). Sannabis has an ICA site visit this week for approval of their Seed Bank by the Justice Ministry.

The Derivative Fabrication License allows Sannabis to extract cannabinoids, oils, distillates, isolates and to manufacture final products for both national and export markets. The global cannabidiol market size is expected to reach US$ 23.6 billion, expanding at a CAGR of 22.2%, according to a new study by Grand View Research, Inc. Increasing adoption of cannabidiol (CBD) infused products in various industries such as pharmaceuticals, personal care and cosmetics, and nutraceuticals along with its medical applications is expected to drive the market over the next 7 years.

Sannabis will expand a state-of-the-art production complex near their grow facilities in Cauca, Colombia’s top marijuana growing region, with a library of proven genetics.

Since export of biomass (dried flower) is prohibited by the Colombian government, Sannabis has a company in Uruguay, Campo de Violetas S.A., that can export BioMass. Earlier this year, Company President and Sannabis co-founder, John Campo, was awarded an Import Permit to the U.S. from the United States Department of Agriculture (USDA) for Cannabis from Uruguay. Click here to see a copy of the Cannabis Import Permit. It is important to note, in 2016 Colombia held 40% of the world cannabis quota issued by the International Narcotics Control Board, https://www.incb.org/incb/en/index.html.

Since 2014, Sannabis has been developing, producing, and selling a line of hemp seed oil-based products that are available in Colombia, and being exported to the U.S. For more information visit www.sannabis.co., major product launches to come. Sannabis is an active member of the Cauca community in cannabis relations, having spearheaded the movement 20 years ago to the economic engine it has become. For a history and timeline of Sannabis, visit https://www.tallerlibre.org/historia

“This fabrication license activates the cultivation licenses, so we should have all 4 by year end, once we get the Seed Bank approved this month,” stated Juan Paulo Guzman, Director of Sannabis S.A.S.

John Campo, President of View Systems, Inc. and co-founder of Sannabis added, “these licenses have added incredible value to our company and allow us to work with pharmaceutical and consumer goods companies wanting to enter the Cannabis space with a licensed supplier of high-quality certified derivatives.”

View Systems, Inc. would also like to report that their Form-10Q for Q3’20 will be filed shortly. The Company has been fully reporting for about 20 years and is completing the Sannabis acquisition. Going forward, with new accountants onboard from Colombia and U.S., we don’t anticipate late filings. Our current accountant has been ill causing slight delays, but a new accounting team will take over going forward to account for sales, assets, and liabilities.


About View Systems Inc.

View Systems Inc. provides security and surveillance products to law enforcement facilities such as correctional institutions as well as to government agencies, schools, courthouses, event and sports venues, the military and commercial businesses. View Systems’ products are used by commercial businesses and residential consumers wishing to monitor their assets and limit their liability. For more information, visit www.viewsystems.com

View Systems Inc. (www.viewsystems.com) is the developer of the ViewScan Weapons Detection System, a Department of Homeland Security (DHS) sanctioned product used by law enforcement and correctional facilities, government agencies, schools, courthouses, special events, sports venues, military, and commercial businesses. View Systems acquired Colombian Cannabis company, Sannabis, to diversify into the burgeoning Cannabis industry with new management committed to continue developing their ViewScan Weapons Detection System in Colombia for the local and international market. View Systems intends to file for a name and symbol change in the near future, however, they will continue to develop their newly enhanced state of the art ViewScan products in Barranquilla, Colombia for the local and international markets.

ViewScan is installed at government agencies in Washington, DC and elsewhere, major school systems, correctional facilities, ports, and police stations around the world. View Scan has also been used at events where top security clearance is required for former Presidents. In this Market Survey Report commissioned by the U.S. Department of Homeland Security (DHS), ViewScan demonstrated more features than their top competitors, https://www.dhs.gov/sites/default/files/publications/WTMD-MSR_0614-508.pdf

Company/Media Contact:

View Systems, Inc.
John Campo, President/Chairman
+1-410-236-8200 USA (Office/WhatsApp)
+57-318-657-0918 Colombia (Office)
[email protected]



Blink Charging Acquires U-Go Charging and its Portfolio of EV Charging Stations

Transaction will add 89 additional DC fast and L2 charging stations to the expanding Blink Network

Miami Beach, FL, Nov. 24, 2020 (GLOBE NEWSWIRE) — Blink Charging Co. (Nasdaq: BLNK, BLNKW) (“Blink” or the “Company”), a leading owner, operator, and provider of electric vehicle (EV) charging equipment and services, today announced that it has acquired the EV charging operator U-Go Stations, Inc. and its portfolio of 44 DCFC charging locations. The purchase also includes multiple grants awarded to U-Go, for the deployment of up to an additional 45 new charging stations. The charging stations are located across ten states, expanding Blink’s DCFC footprint.

“As a key contributor to the expanding EV landscape, we are continuously looking for opportunities to strategically broaden our footprint across the United States, and our acquisition of U-Go supports this growth. In addition to their existing charging locations at attractive locations such as hotels, gas stations, and auto dealerships, U-Go has substantial grant awards for more DCFC deployments in Michigan, Pennsylvania, New Jersey, and Vermont. We look forward to installing and operating these new charging locations in early 2021,” commented Brendan Jones, Chief Operating Officer of Blink.

“We are committed to bringing affordable, convenient, and efficient charging stations to the growing population of EV drivers, and the addition of the U-Go portfolio enhances our vital role as a leading provider in the ongoing development of EV infrastructure,” added Mr. Jones.

The acquisition will provide the critical mass necessary to make significant inroads in the DC fast charging market and provide Blink a larger national presence. The U-Go charging stations will add to Blink’s current DCFC portfolio of 88 chargers, predominately found on the West Coast.

Of the existing chargers, 31 are operated on the EVGo network and will be transitioned to the Blink Network within the next 30 days. 13 are not active and will be evaluated for future upgrades. All units will be available to Blink members and guests and can be found at the Blink Mobile App and Blink Map.

U-Go Acquisition Equipment Locations

  • 181 Elm St, Westfield, MA 01085
  • 1600 S Columbus Blvd, Philadelphia, PA 19148
  • 563 Northfield Ave, West Orange, NJ 07052
  • 160 Frontage Rd, Newark, NJ 07114
  • 129 Pehle Ave, Saddle Brook, NJ 07663
  • 1000 International Dr, Budd Lake, NJ 07828
  • 2349 Marlton Pike, Cherry Hill, NJ 08002
  • 1111 Route 73, Mt. Laurel, NJ 08054
  • 9301 2nd Ave, Stone Harbor, NJ 08247
  • East Brunswick, NJ 08816
  • 4 Tower Center Blvd, East Brunswick, NJ 08816
  • 195 Davidson Ave, Somerset, NJ 08873
  • 368 Lewisberry Rd, New Cumberland, PA 17070
  • 16 N George St, York, PA 17401
  • 2600 Keyway Dr, York, PA 17407
  • 3849 Hempland Rd, Mountville PA 17554
  • 5625 Odonnell St, Baltimore, MD 21224
  • Norwood, MA, 02062
  • 1431 Assembly St, Columbia, SC 29201
  • 7421 Garners Ferry Rd, Columbia, SC 29209
  • 730 Coleman Blvd, Mt. Pleasant, SC 29464
  • 3509 Clemson Blvd, Anderson, SC 29621
  • 21229 Olean Blvd, Port Charlotte, FL 33952
  • 32050 US Highway 19 N Palm Harbor, FL 34684
  • Cleveland, TN 37312
  • 109 Sharon Dr, Dandridge, TN 37725
  • 8350 W Grand River Ave, Brighton, MI 48116
  • 2017 N Canton Center Rd, Canton, MI 48187
  • 453 S Gammon Rd, Madison, WI 53719
  • Interstate 25 Exit 259 State Route 22, Santo Domingo, Pueblo, NM 87052
  • 564 N Guadalupe St, Santa Fe, NM 87501

About Blink Charging

Blink Charging Co. (Nasdaq: BLNK, BLNKW) is a leader in electric vehicle (EV) charging equipment and has deployed more than 23,000 charging stations, many of which are networked EV charging stations, enabling EV drivers to easily charge at any of the Company’s charging locations worldwide. Blink Charging’s principal line of products and services include its Blink EV charging network (“Blink Network”), EV charging equipment, and EV charging services. The Blink Network uses proprietary, cloud-based software that operates, maintains, and tracks the EV charging stations connected to the network and the associated charging data. With global EV purchases forecasted to rise to 10 million vehicles by 2025 from approximately 2 million in 2019, the Company has established key strategic partnerships for rolling out adoption across numerous location types, including parking facilities, multifamily residences and condos, workplace locations, health care/medical facilities, schools and universities, airports, auto dealers, hotels, mixed-use municipal locations, parks and recreation areas, religious institutions, restaurants, retailers, stadiums, supermarkets, and transportation hubs. For more information, please visit https://www.blinkcharging.com/.

Forward-Looking Statements

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, and terms such as “anticipate,” “expect,” “intend,” “may,” “will,” “should” or other comparable terms, involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Those statements include statements regarding the intent, belief or current expectations of Blink Charging and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including acquisition-related risks, such as the challenges in integrating acquired assets into Blink Charging’s operations, the occurrence of unforeseen operating difficulties and expenditures, and the diversion of management’s attention away from other parts of the business, as well as others described in Blink Charging’s periodic reports filed with the SEC. There can be no assurance that the U-Go acquisition will prove to be beneficial to the Company. Actual results may differ materially from those contemplated by such forward-looking statements. Except as required by federal securities law, Blink Charging undertakes no obligation to update or revise forward-looking statements to reflect changed conditions.

Blink Media Contact 


[email protected]

Blink Investor Relations Contact 


[email protected]


855-313-8187



Tauriga Sciences Inc.’s Limited Edition Hanukkah Special Now Available on Company’s E-Commerce Website

The Hanukkah Special Gift Pack is Strictly Limited to 613 Units and is Priced at $106.13 per Unit

NEW YORK, NY, Nov. 24, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced that its Limited Edition Hanukkah Special Gift Pack (“Hanukkah Special”) is now available exclusively on the Company’s E-Commerce website (www.taurigum.com).  The Hanukkah Special is strictly limited to 613 Units and the final price has been set $106.13 Each.  The Company is confident that this Hanukkah Special will have a positive effect on this Quarter’s E-Commerce sales (3rd Fiscal Quarter 2021).

The Hanukkah Special Gift Pack is comprised of the following:

( ) = Quantity of Each Component per Hanukkah Special

1.  (1) Tauri-Gum™ Rainbow Pack

2.  (2) Dark Chocolate CBD Infused Coins <20mg>

3.  (1) Painted Wooden Dreidel

4.  (1) Collectible Decorative Hanukkah Pouch

5.  (1) Raffle Entry for Solid 14 Karat Gold Dreidel Necklace

Click on the Below Link (To Purchase Hanukkah Special):

Link:    https://taurigum.com/products/hannukah-gift-special

In other news, the Company is experiencing accelerated growth in its highest margin E-Commerce business segment.  This growth has largely been driven by the recent launch of its Rainbow Pack ($99.99 Each).  On November 16, 2020 the Company announced that it had received its 4,000th E-Commerce order.  As of this morning, the Company has already received its 4,170th  E-Commerce order.

Lastly, the Company is close to achieving an important corporate milestone.  The Company’s Instagram Page, @taurigum, has secured approximately 9,000 Followers.  Once the 10,000 Followers threshold is reached, the Company believes that it will have a positive effect on its E-Commerce Business.  

Below, Link to @taurigum Instagram Page:

Link:  https://www.instagram.com/taurigum/

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Tauri-Gum™ Flavor: Pear Bellini).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com

Complementary to the Company’s retail business, are its two ongoing biotechnology initiatives.  The first one relates to the development of a Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment). On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second one relates to a collaboration agreement with Aegea Biotechnologies Inc. for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity.   

On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4)

On October 7, 2020 the Company disclosed a Strategic Alliance with Think BIG, LLC, Social Impact Startup Founded by CJ Wallace, Son of Christopher “The Notorious B.I.G.” Wallace.

The Company is headquartered in New York City and operates a regional office in Barcelona, Spain.  In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.

DISCLAIMER — Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

Tauriga Sciences, Inc.

555 Madison Avenue, 5th Floor

New York, NY  10022

Chief Executive Officer

Mr. Seth M. Shaw

Email: [email protected]

cell # (917) 796 9926

Instagram: @taurigum

Twitter: @SethMShaw

Corp. Website:  www.tauriga.com

E-Commerce Website:  www.taurigum.com

Attachment



Hanes Donates Nearly 1.3 Million Face Masks and Pairs of Socks in 2020 to Support the Homeless During the COVID-19 Pandemic

Hanes Donates Nearly 1.3 Million Face Masks and Pairs of Socks in 2020 to Support the Homeless During the COVID-19 Pandemic

Ahead of #GivingTuesday and the holiday season, America’s No. 1 basic apparel, underwear and sock brand is asking everyone to join in supporting those who are most vulnerable

WINSTON-SALEM, N.C.–(BUSINESS WIRE)–
Imagine trying to protect yourself, your children, your family against COVID-19 while living without shelter or the basic necessities of life.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201124005599/en/

America’s growing homeless population is among the most vulnerable during the COVID-19 pandemic, and that is why Hanes is encouraging everyone to join together to support those living without shelter ahead of #GivingTuesday.

During 2020, America’s No. 1 basic apparel, underwear and sock brand has supported nearly 400 organizations fighting homelessness in all 50 states, along with Washington, D.C., and Puerto Rico. The brand has:

  • Donated more than 1 million masks, enabling those experiencing homelessness access to public resources and facilities while helping to reduce the spread of the COVID-19 virus.
  • Provided nearly 300,000 pairs of socks, which help keep feet clean, comfortable and healthy for people who walk an average of 10 miles per day. Since the program’s inception in 2009, Hanes has provided more than 3 million pairs of socks – one of the items relief agencies request most.
  • Partnered with Rainier Fruit Company for the third “Pears for Pairs” campaign – currently running in United Supermarkets, Harris Teeter and Wegmans locations across the country – on a program that donates a portion of the proceeds from bulk and bagged pear sales to purchase socks. In 2019, the campaign resulted in 25,000 pairs of socks being distributed to four nonprofits serving those living homeless.
  • Continued its 11-year partnership with Invisible People and its founder and homeless advocate, Mark Horvath, to distribute socks and raise awareness about homelessness in the United States and around the world.

“The COVID-19 pandemic has changed life for us all, but this year has been exceptionally rough for people experiencing homelessness,” Horvath said. “The economic impact and lack of affordable housing continues to significantly increase homeless numbers, while homeless shelters have had to reduce capacity and are faced with more need yet fewer resources to help.

And the outlook is grim as dropping temperatures and the flu season are added to the mix.

“Invisible People is proud to partner with Hanes to make a difference through product donations and by encouraging people to support their local homeless services,” he continued. “Now more than ever, our homeless population needs support – and there is something that everyone can do to help.”

The needs vary from community to community. For example, The Road Home in Salt Lake City is requesting hats, gloves and snow boots, while Roof Above in Charlotte, North Carolina, is asking for towels and blankets. Merideth Spriggs, founder and chief kindness officer for CARIDAD in Las Vegas, notes the importance of community support.

“Due to quarantine restrictions, the homeless are not able to get their basic needs met – they might not have a mask, they may not be able to get to water sources, or they might have a cup that they can’t refill because of the new restrictions,” Spriggs said. “Just be aware of that and if you see a homeless person, share the love. Giving them something as simple as a bottle of water can change, or, quite honestly, save somebody’s life.”

Sidney Falken, chief branding officer for HanesBrands, said, “We know that product donations are very meaningful to those experiencing homelessness, and we are honored to help. It takes all of us to help support our communities, and we urge everyone to try to do their part to make a difference.”

Learn more about homelessness, how COVID-19 is impacting those living homeless, the organizations Hanes is partnering with and how everyone can make difference in the lives of those who need it most on Hanes For Good (www.HanesForGood.com). The new site is dedicated to the brand’s social purpose activities.

Hanes

Hanes, America’s No. 1 apparel brand, is a leading brand of intimate apparel, underwear, sleepwear, socks and casual apparel. Hanes products can be found at leading retailers nationwide and online direct to consumers at www.Hanes.com.

HanesBrands

HanesBrands is a socially responsible leading marketer of everyday basic innerwear and activewear apparel in the Americas, Europe, Australia and Asia-Pacific. The company markets T-shirts, bras, panties, shapewear, underwear, socks, hosiery, and activewear under some of the world’s strongest apparel brands, including Hanes, Champion, Bonds, Maidenform, DIM,Bali, Playtex, Bras NThings, Nur Die/Nur Der, Alternative, L’eggs, JMS/Just My Size, Lovable, Wonderbra, Berlei, and Gear for Sports. More information about the company and its award-winning corporate social responsibility initiatives may be found at www.Hanes.com/corporate. Visit our newsroom at https://newsroom.hanesbrands.com/. Connect with the company via social media: Twitter (@hanesbrands), Facebook (www.facebook.com/hanesbrandsinc), Instagram (@hanesbrands), and LinkedIn (@Hanesbrandsinc).

Carole Crosslin, HanesBrands

336-671-3704 (mobile)

[email protected]

Jamie Wallis, Hanes

914-229-8973 (mobile)

[email protected]

KEYWORDS: North Carolina United States North America

INDUSTRY KEYWORDS: Fashion Philanthropy Retail Manufacturing Other Philanthropy Textiles

MEDIA:

Logo
Logo